BERLIN — Swiss pharmaceutical company Novartis says it has signed an agreement to help production of the Pfizer-BioNTech coronavirus vaccine.
Novartis says the initial agreement calls for it to take active ingredient from Germany’s BioNTech and fill it into vials at its plant in Stein, Switzerland. The vials would be sent back to BioNTech for distribution.
Novartis says the plan is for it to start production during the second quarter, with the initial shipment of finished vaccines expected in the third quarter.
Novartis’ announcement comes after another rival, French drugmaker Sanofi, said Wednesday it would help bottle and package the BioNTech-Pfizer vaccine at a plant in Frankfurt.
GENEVA (AP) — The World Health Organization said Friday that COVID-19 no longer qualifies as a global emergency, marking a symbolic end to the devastating coronavirus pandemic that triggered once-unthinkable lockdowns, upended economies and killed millions of people worldwide.
FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.
Explore articles from the past and connect to your heritage!
Discover the benefits of a subscription including access to exclusive content, events, and more!
Have an idea for a story, or know of an event we should cover? We want to hear about it!
The National Herald is the paper of record of the Greek Diaspora community. Through independent journalism, we bring news to generations of Greek-Americans, with stories on the individual, community and international level. Visit and support our 106 year-old sister publication Εθνικός Κήρυξ.
To purchase a gift subscription, please log out of your account, and purchase the subscription with a new email ID.
Sign up to receive our daily email news briefing.
Sign up for a subscription to The National Herald,
starting as low as $1/week.
and receive more access to The National Herald
View our Terms of Service + Privacy Policy.
and receive more access to The National Herald
View our Terms of Service + Privacy Policy.
We use cookies on our site to personalize your experience, bring you the most relevant content, show you the most useful ads, and to help report any issues with our site. You can update your preferences at any time by visiting preferences. By selecting Accept, you consent to our use of cookies. To learn more about how your data is used, visit our cookie policy.
$1.08 USD
